FIELD: medicine.
SUBSTANCE: application of 5a-androst-3b,5,6b-triol and analogue thereof, a deuterated derivative, or pharmaceutically acceptable salts thereof for producing a medicinal product for treating hemorrhagic stroke is proposed in the present invention. Hemorrhagic stroke constitutes an intracerebral hemorrhage, or a subarachnoid hemorrhage, or both described types of hemorrhage.
EFFECT: provided is application of 5a-androst-3b,5,6b-triol and analogue thereof, a deuterated derivative, or pharmaceutically acceptable salts thereof in treatment of hemorrhagic stroke.
18 cl, 3 dwg, 1 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| APPLICATION OF THE COMPOUND FOR THE PREPARATION OF A DRUG FOR THE TREATMENT OF CEREBRAL MICROANGIOPATHY | 2018 | 
 | RU2752089C1 | 
| SHORT-TERM ACTING DIHYDROPYRIDINES (CLEVIDIPINE) FOR RECOVERY AFTER STROKE | 2012 | 
 | RU2623039C2 | 
| METHOD OF DETERMINING INDICATIONS FOR CARRYING OUT INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE PERIOD OF ISCHEMIC STROKE | 2010 | 
 | RU2444990C1 | 
| METHOD OF PREDICTING OUTCOME OF PRIMARY INTRACEREBRAL HEMORRHAGE WITHIN 90 DAYS | 2023 | 
 | RU2810021C1 | 
| METHOD OF DIAGNOSING CHANGES IN PERIFOCAL REGION DURING SMALL SUPRATENTORIAL INTRACEREBRAL BLEEDING | 2008 | 
 | RU2363380C1 | 
| METHOD FOR PREDICTION OF SEPSIS DEVELOPMENT IN PATIENTS WITH NONTRAUMATIC INTRACEREBRAL BLEEDING | 2016 | 
 | RU2641174C2 | 
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 | 
 | RU2426535C2 | 
| HAPTOGLOBIN FOR USE IN TREATMENT OF UNFAVORABLE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING HAEMORRHAGIC STROKE | 2020 | 
 | RU2818474C2 | 
| METHOD FOR CORRECTING THE NEUROLOGICAL STATUS WITH 2-ETHYL-6-METHYL-3-HYDROXY PYRIDINIUM-N-ACETYLAMINOACETATE IN CASE OF BRAIN DAMAGE DUE TO INTRACEREBRAL HEMORRHAGE IN THE EXPERIMENT | 2022 | 
 | RU2786315C1 | 
| CHLORIDE SALT OF PEPTIDE TAT-NR2B9c COMPOSITION, BASED THEREON AND METHODS FOR PRODUCTION THEREOF | 2015 | 
 | RU2707885C2 | 
Authors
Dates
2021-07-22—Published
2018-12-28—Filed